FDA Committee Supports Simple DNA Tests When Patients Are Prescribed Coumadin (Warfarin)

... A blue-ribbon advisory committee to the FDA has recommended genotyping patients at the beginning of Coumadin (generic name warfarin) therapy to allow patients to be more quickly stabilized at safe and effective dosage levels. The FDA committee points out that genotyping by DNA testing can help to reduce potentially fatal and serious adverse reactions to the drug. [click link for full article] ...